LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin

By Walker R.A.   Skinner J.A.   Ward L.R.   Threlfall E.J.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 6, 2003-12 ,pp. : 622-625

Elsevier

Access to resources Recommend Favorite

CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients

By Kim Seung-Hyun   Ye Young-Min   Hur Gyu Young   Lee Soo-Keol   Sampson Anthony P   Lee Hyun-Young   Park Hae-Sim  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1143-1150

Future Medicine

Access to resources Recommend Favorite

The Safety of H1N1 Vaccine in Children in Saudi Arabia: A Cohort Study Using Modern Technology in a Developing Country

By Aljadhey Hisham  

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 555-561

Adis International

Access to resources Recommend Favorite

COLIA1 Sp1 polymorphism: towards individualized therapy with injected recombinant hGH in GH-deficient adults?

By Koch Christian A  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 987-988

Future Medicine

Access to resources Recommend Favorite

Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults

By Meyer Silke   Haist Marlitt   Schaefer Stephan   Ivan Diana   Ittner Jochen R   Nawroth Peter P   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Habbe Nils   Kann Peter H  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1017-1026

Future Medicine

Access to resources Recommend Favorite